Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical studyT M Behr, A L Salib, T Liersch, et al.
British Journal of Cancer|July 18, 2013
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical resultsR Schoffelen, O C Boerman, D M Goldenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trialK Kalinsky, J R Diamond, L T Vahdat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2020
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot studyY Touchefeu, C Bailly, E Frampas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical studyT M Behr, A L Salib, T Liersch, et al.
British Journal of Cancer|July 18, 2013
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical resultsR Schoffelen, O C Boerman, D M Goldenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trialK Kalinsky, J R Diamond, L T Vahdat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2020
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot studyY Touchefeu, C Bailly, E Frampas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.
Pageof 15